INHIBIKASE Trademark

Trademark Overview

On Thursday, October 25, 2018, a trademark application was filed for INHIBIKASE with the United States Patent and Trademark Office. The USPTO has given the INHIBIKASE trademark a serial number of 88169711. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by Inhibikase Therapeutics, Inc.. The INHIBIKASE trademark is filed in the Pharmaceutical Products category with the following description:

prescription pharmaceuticals to treat neurodegeneration
inhibikase

General Information

Serial Number88169711
Word MarkINHIBIKASE
Filing DateThursday, October 25, 2018
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6760689
Registration DateTuesday, June 14, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements

Goods and Servicesprescription pharmaceuticals to treat neurodegeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 10, 2022
Primary Code005
First Use Anywhere DateTuesday, August 31, 2021
First Use In Commerce DateTuesday, August 31, 2021

Trademark Owner History

Party NameInhibikase Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameInhibikase Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameInhibikase Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Friday, February 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 29, 2018NEW APPLICATION ENTERED
Thursday, November 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 1, 2019ASSIGNED TO EXAMINER
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 8, 2019SOU TEAS EXTENSION RECEIVED
Friday, November 8, 2019SOU EXTENSION 1 FILED
Friday, November 8, 2019SOU EXTENSION 1 GRANTED
Wednesday, May 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2020SOU TEAS EXTENSION RECEIVED
Monday, May 11, 2020SOU EXTENSION 2 FILED
Monday, May 11, 2020SOU EXTENSION 2 GRANTED
Monday, November 9, 2020SOU EXTENSION 3 GRANTED
Monday, November 9, 2020SOU TEAS EXTENSION RECEIVED
Monday, November 9, 2020SOU EXTENSION 3 FILED
Wednesday, May 12, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 12, 2021SOU EXTENSION 4 FILED
Wednesday, May 12, 2021SOU EXTENSION 4 GRANTED
Friday, May 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 30, 2021USE AMENDMENT FILED
Tuesday, October 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 14, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 9, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 30, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, November 9, 2021SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 9, 2021NON-FINAL ACTION E-MAILED
Friday, May 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 11, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 29, 2022SOU EXTENSION 5 GRANTED
Thursday, November 11, 2021SOU EXTENSION 5 FILED
Wednesday, March 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 10, 2022ASSIGNED TO LIE
Tuesday, May 10, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 11, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, June 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

inhibikase neurodegeneration treat pharmaceuticals prescription